A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Marketnews2024-03-08T15:06:16+00:00March 8th, 2024|The New York Times|
F.D.A. Delays Action on Closely Watched Alzheimer’s Drugnews2024-03-08T11:45:07+00:00March 8th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
What to Know About Ibogaine, a Psychedelicnews2024-03-05T08:00:07+00:00March 5th, 2024|The New York Times|
Se retiran de CVS y Walmart pomadas oftálmicas por riesgo de infecciónnews2024-02-29T11:45:18+00:00February 29th, 2024|The New York Times|
Eye Ointments at CVS and Walmart Pulled Because of Infection Risknews2024-02-28T04:24:35+00:00February 28th, 2024|The New York Times|
Can You Recycle Medical Devices Like Insulin Pens, Inhalers and Covid Tests?news2024-02-26T17:51:01+00:00February 26th, 2024|The New York Times|
Severe Frostbite Gets a Treatment That May Prevent Amputationnews2024-02-24T10:04:21+00:00February 24th, 2024|The New York Times|
NY AG Urges Stricter Asthma Drug Warnings Due to Children’s Mental Health Risksnews2024-02-22T21:27:36+00:00February 22nd, 2024|The New York Times|
Gene Therapies Could Transform Rare Diseases. Are We Holding Them Back?news2024-02-19T22:47:36+00:00February 19th, 2024|The New York Times|
